Page 138 - 南京医科大学学报自然科学版
P. 138

第43卷第6期
               ·880 ·                            南 京    医 科 大 学 学         报                        2023年6月


             [16] BORGGREVE A S,GOENSE L,VAN ROSSUM P S N,et         107:128-137
                   al. Preoperative prediction of pathologic response to neo⁃  [26] 王  璐. 基于PET/CT模拟定位系统的靶区勾画对老年
                   adjuvant chemoradiotherapy in patients with esophageal  食管癌调强放疗心脏的剂量学研究[J]. 当代医学,
                            18
                   cancer using F⁃FDG PET/CT and DW⁃MRI:a prospec⁃   2021,27(30):157-159
                   tive multicenter study[J]. Int J Radiat Oncol Biol Phys,  [27] HSU S W,CHANG J S,CHANG W L,et al. Measuring
                   2020,106(5):998-1009                              distance from the incisors to the esophageal cancer by
             [17] EYCK B M,ONSTENK B D,NOORDMAN B J,et al.           FDG PET/CT:endoscopy as the reference[J]. BMC Gas⁃
                   Accuracy of detecting residual disease after neoadjuvant  troenterol,2022,22(1):126
                                                                                                        68
                   chemoradiotherapy for esophageal cancer:a systematic  [28] LIU H,HU Z,YANG X,et al. Comparison of[ Ga]Ga⁃
                   review and meta⁃analysis[J]. Ann Surg,2020,271(2):  DOTA⁃FAPI⁃04 and[ F]FDG uptake in esophageal can⁃
                                                                                     18
                   245-256                                           cer[J]. Front Oncol,2022,12:875081
                                                                                                         89
             [18] BOELLAARD R,DELGADO⁃BOLTON R,OYEN W J,et      [29] ZHENG K H,KROON J,SCHOORMANS J,et al. Zr⁃la⁃
                   al. FDG PET/CT:EANM procedure guidelines for tumour  beled high ⁃ density lipoprotein nanoparticle pet imaging
                   imaging:version 2.0[J]. Eur J Nucl Med Mol Imaging,  reveals tumor uptake in patients with esophageal cancer
                   2015,42(2):328-354                               [J]. J Nucl Med,2022,63(12):1880-1886
                                                                            18
             [19] BREIK O,KUMAR A,BIRCHALL J,et al. Follow up   [30] 董印军. F——Alfatide PET/CT 食管癌整合素受体显
                   imaging of oral,oropharyngeal and hypopharyngeal can⁃  像及图像纹理预测价值研究[D]. 济南:山东大学,
                   cer patients:comparison of PET⁃CT and MRI post treat⁃  2019
                   ment[J]. J Cranio Maxillo Facial Surg,2020,48(7):  [31] LIN A,HAHN S M. Hypoxia imaging markers and appli⁃
                   672-679                                           cations for radiation treatment planning[J]. Semin Nucl
             [20] HAN S,KIM Y J,WOO S,et al. Prognostic value of volu⁃  Med,2012,42(5):343-352
                                                                                           18
                                             18
                   metric parameters of pretreatment F ⁃ FDG PET/CT in  [32] 陈灯运,徐慧琴,张  丹,等. F⁃硝基咪唑丙醇正电子
                   esophageal cancer:a systematic review and meta⁃analysis  发射断层显像/X 线计算机体层成像对食管癌放疗前
                  [J]. Clin Nucl Med,2018,43(12):887-894             后乏氧情况的监测及疗效评价[J]. 安徽医药,2022,26
             [21] TUSTUMI F ,DUARTE P S,ALBENDA D G,et al. Prog⁃    (5):887-890
                                                                                              18
                   nostic value of  18 F ⁃ fluorodeoxyglucose PET/computed  [33] 陈丽敏. 新型 PET 乏氧显像剂 F⁃HX4 的临床研究
                   tomography metabolic parameters measured in the primary  [D]. 上海:复旦大学,2010
                   tumor and suspicious lymph nodes before neoadjuvant  [34] KLAASSEN R,BENNINK R J,VAN TIENHOVEN G,et
                   therapy in patients with esophageal carcinoma[J]. Nucl  al. Feasibility and repeatability of PET with the hypoxia
                                                                          18
                   Med Commun,2021,42(4):437-443                     tracer[ F]HX4 in oesophageal and pancreatic cancer
             [22] GOPAL A ,XI Y,SUBRAMANIAM R M,et al. Intratu⁃     [J]. Radiother Oncol,2015,116(1):94-99
                                                                                                    18
                                                         18
                   moral metabolic heterogeneity and other quantitative F⁃  [35]CHEN H,LI Y,WU H,et al. 3’⁃deoxy⁃3’⁃[ F]⁃fluorothy⁃
                   FDG PET/CT parameters for prognosis prediction in  midine PET/CT in early determination of prognosis in pa⁃
                   esophageal cancer[J]. Radiol Imaging Cancer,2020,3  tients with esophageal squamous cell cancer:comparison
                                                                         18
                  (1):e200022                                        with[ F]⁃FDG PET/CT[J]. Strahlenther Onkol,2015,
             [23] WANG C,ZHAO K,HU S,et al. The PET⁃derived tumor⁃   191(2):141-152
                   to⁃liver standard uptake ratio[SUV(TLR)]is superior to  [36] HOTTA M,MINAMIMOTO R,TOYOHARA J,et al. Effi⁃
                   tumor SUVmax in predicting tumor response and survival  cacy of cell proliferation imaging with 4DST PET/CT for
                   after chemoradiotherapy in patients with locally advanced  predicting the prognosis of patients with esophageal can⁃
                   esophageal cancer[J]. Front Oncol,2020,10:1630    cer:a comparison study with FDG PET/CT[J]. Eur J Nu⁃
             [24] JAYAPRAKASAM V S ,GIBBS P,GANGAI N,et al.          cl Med Mol Imaging,2021,48(8):2615-2623
                      18
                   Can F⁃FDG PET/CT radiomics features predict clinical  [37] NARUSHIMA K,NISHIL R,OKAZUMI S,et al.[S⁃meth⁃
                   outcomes in patients with locally advanced esophageal  yl⁃11C]⁃L⁃methionine positron emission tomography/com⁃
                   squamous cell carcinoma?[J]. Cancers,2022,14(12):  puted tomography imaging parameters to evaluate early re⁃
                   3035                                              sponse for esophageal cancer with neoadjuvant carbon ion
             [25] LU J,SUN X D,YANG X,et al. Impact of PET/CT on ra⁃  radiotherapy[J]. Sci Rep,2022,12(1):13694
                   diation treatment in patients with esophageal cancer:a                 [收稿日期] 2023-02-09
                   systematic review[J]. Crit Rev Oncol Hematol,2016,                          (本文编辑:陈汐敏)
   133   134   135   136   137   138   139   140   141   142   143